We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Ac-Leu-Arg-AMC is a fluorogenic peptide substrate.
CAT No: R1149
CAS No: 929621-79-4
Synonyms/Alias: Ac-Leu-Arg-AMC;929621-79-4;(2S)-2-acetamido-N-[(2S)-5-(diaminomethylideneamino)-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopentan-2-yl]-4-methylpentanamide;DTXSID501150013;HY-P1448;DA-60770;MS-29041;PD099883;CS-0034435;G16226;N-Acetyl-L-leucyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-argininamide;(S)-2-Acetamido-N-((S)-5-guanidino-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)-4-methylpentanamide;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C24H34N6O5 |
M.W/Mr. | 486.6 |
Sequence | One Letter Code:LR Three Letter Code:Ac-Leu-Arg-AMC |
InChI | InChI=1S/C24H34N6O5/c1-13(2)10-19(28-15(4)31)23(34)30-18(6-5-9-27-24(25)26)22(33)29-16-7-8-17-14(3)11-21(32)35-20(17)12-16/h7-8,11-13,18-19H,5-6,9-10H2,1-4H3,(H,28,31)(H,29,33)(H,30,34)(H4,25,26,27)/t18-,19-/m0/s1 |
InChI Key | YAPHUDCEMGABMM-OALUTQOASA-N |
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.